scispace - formally typeset
J

Josefina Liñares

Researcher at University of Barcelona

Publications -  189
Citations -  10539

Josefina Liñares is an academic researcher from University of Barcelona. The author has contributed to research in topics: Streptococcus pneumoniae & Penicillin. The author has an hindex of 50, co-authored 189 publications receiving 10068 citations. Previous affiliations of Josefina Liñares include Bellvitge University Hospital & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

TL;DR: Current levels of resistance to penicillin and cephalosporin by S. pneumoniae are not associated with increased mortality in patients with pneumococcal pneumonia, and these antibiotics remain the therapy of choice for this disease.
Journal ArticleDOI

Emerging Importance of Multidrug-Resistant Acinetobacter Species and Stenotrophomonas maltophilia as Pathogens in Seriously Ill Patients: Geographic Patterns, Epidemiological Features, and Trends in the SENTRY Antimicrobial Surveillance Program (1997–1999)

TL;DR: The geographic differences in resistance patterns among Acinetobacter species and S. maltophilia isolates observed in this study emphasize the importance of local surveillance in determining the most adequate therapy for acinetobacterial infections and the possible clonal, epidemic nature of occurrence.
Journal ArticleDOI

Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments.

TL;DR: The catheter hub is the most common site of origin of organisms causing catheter tip infection and bacteremia in patients on total parenteral nutrition.
Journal ArticleDOI

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci.

TL;DR: It is suggested that pneumonia due to penicillin-resistant pneumococci may occur more often in a population with some identifiable risk factors, and may respond to intravenous high-dosePenicillin therapy if MICs are less than or equal to 2 micrograms per milliliter.
Journal ArticleDOI

Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases

TL;DR: An outbreak due to extended-spectrum β-lactamase-producingKlebsiella pneumoniae (ESBL-KP) was detected from May 1993 to June 1995, and primary bacteremia caused by ESBL- KP was the most frequent infection.